Singular Genomics Systems Inc
OMIC
NGS
Sector: Manufacturing
Industry: Analytical Laboratory Instrument Manufacturing
3.97
USD
0.53
(15.41%)
Optionable: No Market Cap: 314 M 90-day average vol: 376,689
Previous close: 3.44 Open: 3.37 Bid: 4.0 Ask: 4.0
52 week range
2.64 18.19
Last updated: Friday 12th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 0.00 |
Price per Book TTM ($) | 1.03 |
PE Ratio (TTM) | -2.60 |
Book Value per Share ($) | 4.50 |
5 Year PE Range | -5.5 , -5.7 |
Returns
7 Day Return | -4.34% | |
1 Month Return | -5.48% | |
3 Month Return | 20.30% | |
1 Year Return | -73.93% | |
3 Year Return | -84.56% | |
5 Year Return | -84.56% | |
YTD Return | -65.66% |
Risk
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 50.29 |
14 Day SMA ($) | 3.94 |
14 Day EMA ($) | 4.01 |
Money Flow Index | 70.96 |
Average True Range | 0.45 |
50 Day SMA ($) | 3.74 |
200 Day SMA ($) | 7.22 |
ADX | 20.21 |
MACD | 0.06 |
Growth
Free Cash Flow QoQ Growth | 0.00% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | 0.00% |
Revenue QoQ Growth | 0.00% |
EPS YoY Growth | 0.00% |
Profitability
Chart
News
Singular Genomics Systems, Inc. (OMIC) Q4 2021 Earnings Call Transcript
Yahoo Finance 3/3/2022
Singular Genomics Systems, Inc. (OMIC) CEO Drew Spaventa on Q4 2021 Results - Earnings Call Transcript
Seeking Alpha 3/2/2022
Singular Genomics Systems GAAP EPS of -$0.27 beats by $0.03
Seeking Alpha 3/2/2022
Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results
Yahoo Finance 3/2/2022
Singular Genomics Systems, Inc. to Present at the 42nd Annual Cowen Health Care Conference
Yahoo Finance 3/1/2022
Singular Genomics inks partnerships with Agilent and Qiagen for sequencing platform
Seeking Alpha 2/28/2022
Singular Genomics Partners with Agilent to Enable the SureSelect Target Enrichment Reagents for the G4 Sequencing Platform
Yahoo Finance 2/28/2022
Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform
Yahoo Finance 2/28/2022
Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits
Yahoo Finance 2/28/2022
Singular Genomics Systems, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022
Yahoo Finance 2/23/2022
16 unloved stocks ripe for a rally: Bank of America
Yahoo Finance 1/18/2022
Singular Genomics Systems (OMIC) presents at 40th JPMorgan Annual Healthcare Conference (Slideshow)
Seeking Alpha 1/11/2022
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: -8.985
Financials
OMIC Income Statement
Annual
| Invalid date | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | |
| Cost of sales | -340000 | -722000 | -3 M | |
| Gross operating profit | 0 | 0 | 0 | |
| Selling Gen & administrative expense | 2 M | 6 M | 29 M | |
| Research & development expense | 10 M | 21 M | 33 M | |
| Operating income | -13 M | -28 M | -61 M | |
| floaterest income | 0 | 0 | 0 | |
| floaterest expense | 0 | 0 | 0 | |
| Other income net | 0 | -157000 | -37 M | |
| Pre-tax Income (EBT) | -12 M | -28 M | -99 M | |
| Income taxes | 0 | 0 | 0 | |
| Net income from total operations | -12 M | -28 M | -99 M | |
| Minority floaterest | 0 | 0 | 0 | |
| Total net income | -12 M | -28 M | -99 M | |
| Preferred dividends | N/A | N/A | N/A | |
| Net income available for common | -12 M | -28 M | -99 M | |
| Depreciation | 340000 | 722000 | 3 M | |
| Amortization | 0 | 0 | 0 | |
| Operating income before depreciation (EBITDA) | -12 M | -27 M | -97 M | |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | |
| Basic EPS total | -0.25 | -0.56 | -2.1 | |
| Diluted EPS total | -0.25 | -0.56 | -2.1 |
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!